Search results
Results from the WOW.Com Content Network
Discover Oncology, formerly Hormones and Cancer, is a bimonthly peer-reviewed medical journal covering research on all aspects of hormone action on cancer. It was established in 2010 and is published by Springer Science + Business Media on behalf of The Endocrine Society. The editor-in-chief is Carol A. Lange (University of Minnesota).
JCO Global Oncology is a peer-reviewed open-access medical journal covering cancer care, research, and care delivery issues unique to countries and settings with limited healthcare resources. It was established in 2015 as the Journal of Global Oncology , obtaining its current name in 2020.
While these journals still did not receive an impact factor until the next year, they did contribute citations to the calculation of other journals' impact factors. [4] [5] In July 2022, Clarivate announced that journals in the ESCI obtain an impact factor effective from JCR Year 2022 first released in June 2023. [6]
Oncology: Language: English: Edited by: ... the journal has a 2020 impact factor of 39.397. [6] ... This page was last edited on 30 April 2023, ...
Oncology: Language: English: Edited by: ... the journal has a 2023 impact factor of 14.8. [1] References ... This page was last edited on 15 October 2024, ...
GoodRx released a list of 19 of the most influential drugs and vaccines approved by the FDA in 2024 to treat a variety of conditions. These medications are “slated to make a big clinical impact."
Cellular Oncology is a bimonthly peer-reviewed medical journal published by Springer Science+Business Media. [1] The journal was established in 1989 as Analytical Cellular Pathology, obtaining its current name in 2003. [2] [3] It is an official publication of the International Society for Cellular Oncology and is published
Several recalls were issued in 2024 for Ford Motor Company vehicles. The recall report data is from Jan. 1, 2024, to Dec. 27, 2024. The U.S. Department of Transportation (DOT) compiles data from ...